<DOC>
	<DOCNO>NCT00878189</DOCNO>
	<brief_summary>This phase 1 , dose escalate study determine safety PF-03084014 patient advance cancer leukemia</brief_summary>
	<brief_title>A Trial In Patients With Advanced Cancer And Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Neoplasms Histologic Type</mesh_term>
	<criteria>Patients advance cancer resistant standard therapy standard therapy available Patients acute T cell leukemia/lymphoblastic lymphoma resistant standard therapy standard therapy available Men woman &gt; 16 year old Prior treatment gamma secretase inhibitor treatment cancer Patients take Tamoxifen Patients active graft versus host disease Known human immunodeficiency virus ( HIV ) acquire immunodeficiency syndrome ( AIDS ) relate illness Patients pregnant breast feeding Patients clinical evidence central nervous system disease</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Phase 1 dose escalation study advance solid tumor malignancy leukemia</keyword>
</DOC>